{"id":886,"date":"2025-02-27T15:17:59","date_gmt":"2025-02-27T15:17:59","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/?page_id=886"},"modified":"2025-05-20T06:07:21","modified_gmt":"2025-05-20T06:07:21","slug":"estudio-internacional-sobre-la-enfermedad-de-parkinson-de-rostock-ropad","status":"publish","type":"page","link":"https:\/\/www.centogene.com\/es\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/","title":{"rendered":"ROPAD"},"content":{"rendered":"<section class=\"bloque-banner-titulo-page  estilo-grey\" id=\"\">\r\n    \r\n    <div class=\"image-wrapper\">\r\n\r\n      <!-- include mp4 video on a loop -->\r\n              <img decoding=\"async\" class=\"\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-clinical-trails_ROPAD-header_1e7a809eb7.webp\" alt=\"csm_centogene-pharma-clinical-trails_ROPAD-header_1e7a809eb7\" \/>\r\n          <\/div>\r\n    <div class=\"container content-wrapper\">\r\n      <div class=\"row justify-content-start align-items-center\">\r\n\r\n\r\n        <div class=\"col-12 col-lg-6 animation fadeTop align-self-center\">\r\n                  <h1>ROPAD<\/h1>\r\n          <h2 class=\"bl-texto\">Estudio internacional sobre la enfermedad de Parkinson de Rostock <\/h2>                            <\/div>\r\n\r\n      <\/div>\r\n    <\/div>\r\n\r\n<\/section>\r\n<div class=\"breadcrumbs\">\r\n    <div class=\"container\">\r\n      <div class=\"row\">\r\n        <div class=\"col-12\">\r\n          <ul id=\"breadcrumbs\" class=\"breadcrumbs\"><li><a href=\"https:\/\/www.centogene.com\/es\/\">Inicio<\/a><\/li><\/ul>        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Resumen y justificaci\u00f3n<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Descripci\u00f3n general<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">El Estudio Internacional de Rostock sobre la Enfermedad de Parkinson (ROPAD) es un estudio observacional global centrado en el papel de la gen\u00e9tica en la enfermedad de Parkinson (EP). El objetivo principal del estudio es caracterizar la gen\u00e9tica de la EP para comprender mejor la progresi\u00f3n, el diagn\u00f3stico y el tratamiento de la enfermedad. A lo largo de este estudio, se evaluar\u00e1 a hasta 25\u00a0000 participantes con EP de todo el mundo.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">    <section class=\"bloque-personalizado bloque-cajas-imgs estilo-cajasblancas\" >\n        <div class=\"\"> \n                        <div class=\"row justify-content-between\">\n\n                                        \n                <div class=\"swiper-slide col-12 delay-1 caja\">\n                    <div class=\"caja-inner\" >\n                        <a href=\"https:\/\/www.centoportal.com\/\" target=\"_blank\" class=\"\">                        <div class=\"bl-imagen animationNo scalexTop delay-1\"><img decoding=\"async\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-clinical-trials_study-access-teaser-card_7fbd33e2a0-650x400.webp\" class=\"\" alt=\"\" \/> <\/div>                                               \n                        <\/a>                        \n                        <div class=\"caja-text\">\n                            <p class=\"prefijo\">Ensayos cl\u00ednicos<\/p>                            <h3 class=\"bl-titulo\">Acceso al estudio en CentoPortal\u00ae para los m\u00e9dicos participantes<\/h3>\n                                  \n                                                          <a target=\"_blank\" href=\"https:\/\/www.centoportal.com\/\" class=\"btn btn-primary\">CentoPortal\u00ae<\/a>\n                                                                          \n                        <\/div>                        \n                        \n                    <\/div>      \n                <\/div>       \n                \n                                     \n             \n            \n        <\/div>\n    <\/div>  \n<\/section>\n\n\n\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    fondocolor\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<h2 class=\"wp-block-heading\">Estudio ROPAD: Estrategia racional y de detecci\u00f3n<\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph translation-block\">La enfermedad de Parkinson (EP) puede ser causada por diversos factores, como factores ambientales, gen\u00e9ticos y el envejecimiento. En los \u00faltimos a\u00f1os, se ha descrito un n\u00famero creciente de genes relacionados con la EP, entre ellos <em>LRRK2<\/em> y <em>GBA<\/em> . Por lo tanto, la identificaci\u00f3n de nuevos genes y mutaciones asociados con la EP no solo mejorar\u00e1 nuestra comprensi\u00f3n de los mecanismos moleculares subyacentes, sino que tambi\u00e9n podr\u00eda conducir al desarrollo de nuevos f\u00e1rmacos y tratamientos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">A los participantes con mutaciones <em>en el gen LRRK2<\/em> que cumplan los criterios de elegibilidad se les podr\u00e1 ofrecer la participaci\u00f3n en futuros estudios cl\u00ednicos con nuestros socios que est\u00e1n desarrollando terapias para el tratamiento de enfermedades neurodegenerativas y otras enfermedades humanas.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Informaci\u00f3n sobre el estudio<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dise\u00f1o:<\/strong>&nbsp;Estudio internacional, epidemiol\u00f3gico, observacional y no intervencionista<br><br><strong>Poblaci\u00f3n de estudio:<\/strong>&nbsp;Pacientes con EP&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>N\u00famero de participantes:<\/strong>&nbsp;Hasta 25.000 participantes<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Primer participante en:<\/strong>&nbsp;Abril de 2019<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00daltimo participante en:<\/strong>&nbsp;Diciembre de 2025<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Objetivos:<\/strong>&nbsp;Investigar la prevalencia de etiolog\u00edas gen\u00e9ticas de la EP; Identificar a los participantes con EP LRRK2-positivos de los estratos primarios; Establecer un biomarcador en la cohorte LRRK2-positiva<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><br>Descubre c\u00f3mo puedes participar:&nbsp;<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03866603\" target=\"_blank\" rel=\"noreferrer noopener\">ClinicalTrials.gov<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u00c1mbito geogr\u00e1fico<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full imgborder imgshadow\"><img loading=\"lazy\" decoding=\"async\" width=\"964\" height=\"588\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map.webp\" alt=\"\" class=\"wp-image-884\" srcset=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map.webp 964w, https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map-768x468.webp 768w\" sizes=\"auto, (max-width: 964px) 100vw, 964px\" \/><\/figure>\n\n\n\n<p class=\"has-small-font-size wp-block-paragraph\">Resumen de los pa\u00edses participantes en el estudio ROPAD. La l\u00ednea marca la sede de Centogene GmbH, Rostock, Alemania. (\u00a9 Colaboradores de Mapchart)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ROPAD es un estudio global que se lleva a cabo actualmente en Estados Unidos, Reino Unido, Argentina, Brasil, Alemania, Italia, B\u00e9lgica, Portugal, Espa\u00f1a e Israel. Los pa\u00edses participantes y la distribuci\u00f3n geogr\u00e1fica facilitan un amplio bagaje gen\u00e9tico y \u00e9tnico que refleja la poblaci\u00f3n mundial.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Datos sobre la enfermedad de Parkinson<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Uno de los trastornos neurodegenerativos m\u00e1s comunes en todo el mundo: aproximadamente el 1% de las personas mayores de 60 a\u00f1os se ven afectadas<\/li>\n\n\n\n<li>La probabilidad de desarrollar EP aumenta con la edad y es m\u00e1s frecuente en varones.<\/li>\n\n\n\n<li>Tanto los factores gen\u00e9ticos como los ambientales pueden contribuir a la EP<\/li>\n\n\n\n<li>Se caracteriza por dep\u00f3sitos patol\u00f3gicos de prote\u00ednas t\u00f3xicas en las neuronas, lo que conduce a una deficiencia de neurotransmisores como la dopamina.<\/li>\n\n\n\n<li>Los s\u00edntomas cl\u00ednicos incluyen temblores, rigidez muscular, inestabilidad postural y anomal\u00edas de la marcha.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Dise\u00f1o del estudio e informaci\u00f3n para los participantes:<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">\u00bfQui\u00e9n puede participar en el estudio ROPAD?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>La participaci\u00f3n en el estudio est\u00e1 disponible para personas entre 30 y 80 a\u00f1os de edad y que cumplan los siguientes criterios:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Se proporciona el consentimiento informado.<\/li>\n\n\n\n<li>Diagnosticado cl\u00ednicamente con enfermedad de Parkinson en los \u00faltimos 5 a\u00f1os (\u2264 5 a\u00f1os)<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u00bfQu\u00e9 debo esperar de participar en el estudio ROPAD?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Como participante en el estudio ROPAD, se le pedir\u00e1 que proporcione un formulario de consentimiento firmado, una peque\u00f1a muestra de sangre y una breve historia cl\u00ednica, as\u00ed como que realice un examen neurol\u00f3gico.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La muestra de sangre se enviar\u00e1 y analizar\u00e1 en el laboratorio de CENTOGENE para detectar mutaciones que puedan ser relevantes para la EP.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Si ha aceptado ser informado sobre los resultados de las pruebas gen\u00e9ticas, su m\u00e9dico compartir\u00e1 el informe m\u00e9dico con usted.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tras recibir los resultados de su prueba gen\u00e9tica, su m\u00e9dico podr\u00e1 brindarle m\u00e1s consultas. Durante la terapia, tendr\u00e1 la oportunidad de comprender mejor sus resultados m\u00e9dicos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Trabajando juntos<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CENTOGENE colabora con socios farmac\u00e9uticos que desarrollan terapias en investigaci\u00f3n para el tratamiento de enfermedades neurodegenerativas, entre otras. A los participantes que den positivo en ciertas mutaciones y cumplan los criterios de elegibilidad se les podr\u00eda ofrecer participar en estudios cl\u00ednicos.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<h5 class=\"wp-block-heading\">Recursos<\/h5>\n\n\n\n<h4 class=\"wp-block-heading\">Enlaces \u00fatiles<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03866603\" target=\"_blank\" rel=\"noreferrer noopener\">Descubra c\u00f3mo participar<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.centoportal.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Acceso al estudio en CentoPortal<sup>\u00ae<\/sup>&nbsp;para los m\u00e9dicos participantes<\/a><\/p>\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n  <section class=\"bloque-personalizado bloque-contact-info\" >     \n    <h2 class=\"mt-3 mb-5\"> Contacto Estudio ROPAD<\/h2>   \n    <div class=\"row justify-content-center bordesverticales\"> \n        <div class=\"bl-texto col-12 col-md-3\">\n         <h5 class=\"mt-0\">Para m\u00e1s informaci\u00f3n por favor contactar<\/h5>\n<p><strong>Dr. Jefri Jeya Paul, director s\u00e9nior de proyectos cl\u00ednicos<\/strong><br \/>\nDepartamento de Estudios Cl\u00ednicos<br \/>\nCENTOGENE GmbH<br \/>\nAm Strande 7<br \/>\n18055 Rostock<br \/>\nAlemania<br \/>\nCorreo electr\u00f3nico: <a title=\"Escribe un correo electr\u00f3nico\" href=\"mailto:jefri.paul@centogene.com\" data-mailto-vector=\"-4\">jefri.paul@centogene.com<\/a><\/p>\n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-2\">\n          \n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-3\">\n          <h5 class=\"mt-0\">Estudios cl\u00ednicos<\/h5>\n<h4>Acceso al estudio en CentoPortal para los m\u00e9dicos participantes<\/h4>\n<p><a class=\"btn btn-primary\" title=\"CentoPortal\" href=\"https:\/\/login.centoportal.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">CentoPortal<\/a><\/p>\n        <\/div>\n    <\/div>\n  <\/section>  \n\n  \n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":1078,"menu_order":40,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-886","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ROPAD | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-internacional-sobre-la-enfermedad-de-parkinson-de-rostock-ropad\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ROPAD | CENTOGENE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-internacional-sobre-la-enfermedad-de-parkinson-de-rostock-ropad\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-20T06:07:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map.webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/\",\"name\":\"ROPAD | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/centogene_new_ROPAD_Map.webp\",\"datePublished\":\"2025-02-27T15:17:59+00:00\",\"dateModified\":\"2025-05-20T06:07:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/centogene_new_ROPAD_Map.webp\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/centogene_new_ROPAD_Map.webp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/rostock-international-parkinsons-disease-study-ropad\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trial Support\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"ROPAD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROPAD | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-internacional-sobre-la-enfermedad-de-parkinson-de-rostock-ropad\/","og_locale":"es_ES","og_type":"article","og_title":"ROPAD | CENTOGENE","og_url":"https:\/\/www.centogene.com\/es\/farmaceutica\/apoyo-a-ensayos-clinicos\/estudio-internacional-sobre-la-enfermedad-de-parkinson-de-rostock-ropad\/","og_site_name":"CENTOGENE","article_modified_time":"2025-05-20T06:07:21+00:00","og_image":[{"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map.webp","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/","url":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/","name":"ROPAD | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/#primaryimage"},"image":{"@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/#primaryimage"},"thumbnailUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map.webp","datePublished":"2025-02-27T15:17:59+00:00","dateModified":"2025-05-20T06:07:21+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/#primaryimage","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map.webp","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene_new_ROPAD_Map.webp"},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/rostock-international-parkinsons-disease-study-ropad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"Pharma","item":"https:\/\/www.centogene.com\/pharma\/"},{"@type":"ListItem","position":3,"name":"Clinical Trial Support","item":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/"},{"@type":"ListItem","position":4,"name":"ROPAD"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=886"}],"version-history":[{"count":2,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/886\/revisions"}],"predecessor-version":[{"id":5561,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/886\/revisions\/5561"}],"up":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/1078"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}